Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Replimune Group Inc’s stock clocked out at $12.02, down -4.75% from its previous closing price of $12.62. In other words, the price has decreased by -$4.75 from its previous closing price. On the day, 0.76 million shares were traded. REPL stock price reached its highest trading level at $12.74 during the session, while it also had its lowest trading level at $11.97.
Ratios:
To gain a deeper understanding of REPL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.11 and its Current Ratio is at 10.11. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on August 28, 2024, initiated with a Buy rating and assigned the stock a target price of $17.
On November 19, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $52.Piper Sandler initiated its Overweight rating on November 19, 2021, with a $52 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 16 ’24 when Patel Sushil sold 10,000 shares for $12.42 per share. The transaction valued at 124,200 led to the insider holds 202,014 shares of the business.
Sushil Patel bought 15,000 shares of REPL for $188,550 on Dec 16 ’24. On Nov 18 ’24, another insider, Xynos Konstantinos, who serves as the Chief Medical Officer of the company, sold 7,246 shares for $10.78 each. As a result, the insider received 78,112 and left with 109,885 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REPL now has a Market Capitalization of 925008768 and an Enterprise Value of 466442688.
Stock Price History:
The Beta on a monthly basis for REPL is 1.29, which has changed by 0.3555317 over the last 52 weeks, in comparison to a change of 0.24933672 over the same period for the S&P500. Over the past 52 weeks, REPL has reached a high of $17.00, while it has fallen to a 52-week low of $4.92. The 50-Day Moving Average of the stock is -2.94%, while the 200-Day Moving Average is calculated to be 23.12%.
Shares Statistics:
It appears that REPL traded 771.11K shares on average per day over the past three months and 863490 shares per day over the past ten days. A total of 68.39M shares are outstanding, with a floating share count of 61.23M. Insiders hold about 18.73% of the company’s shares, while institutions hold 81.30% stake in the company. Shares short for REPL as of 1734048000 were 5927772 with a Short Ratio of 7.69, compared to 1731628800 on 6684288. Therefore, it implies a Short% of Shares Outstanding of 5927772 and a Short% of Float of 10.6300004.
